<DOC>
	<DOCNO>NCT01058551</DOCNO>
	<brief_summary>Single site study : The goal study determine incidence new onset atrial fibrillation ( AF ) patient severe obstructive sleep apnea ( OSA ) syndrome use Medtronic Reveal XT implantable Loop recorder ( ILR ) . The ILR device approve use Canada , assessment atrial fibrillation .</brief_summary>
	<brief_title>Incidence Atrial Fibrillation Patients With Severe Obstructive Sleep Apnea : The Reveal XT-SA Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>1 . Patients severe OSA define Apnea Hypopnea Index ( AHI ) &gt; 30 . 2 . Age &gt; 18 year . 1 . Previous history clinical AF define document lone , paroxysmal , persistent permanent , accord standard definition . 2 . Patient anticipate requirement MRI . 3 . Patient wellknow allergy component Medtronic Reveal XT . 4 . Patients implantable cardiac rhythm device [ pacemaker internal cardiac device ( ICDs ) ] . 5 . Women child bear potential . 6 . Unable unwilling provide write informed consent . 7 . Unable unwilling complete study followup schedule ( eg . intention leave Kingston area next 3 year . 8 . Previously enrol trial . 9 . Enrolled another study would confound result trial . 10 . Documented history heart failure 11 . Diagnosed severe obstructive sleep apnea great 1 year screening date</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Sleep Apnea</keyword>
	<keyword>Atrial Fibrillation</keyword>
</DOC>